← Back to Search

Acceptance and Commitment Therapy for Stroke

N/A

Waitlist Available

Led By William Evans, PhD

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants will have an existing diagnosis of aphasia subsequent to left hemisphere stroke.

Participants will be age 18 or older.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and post-treatment (within one week of completing the treatment phase)

Awards & highlights

Study Summary

This trial will adapt Acceptance and Commitment Therapy to better meet the needs of stroke survivors with aphasia by incorporating communication supports and compensatory speech-language treatment in order to improve communication participation, psychosocial adjustment, and quality of life.

Who is the study for?

This trial is for adults over 18 who have aphasia after a stroke in the left side of their brain. It's not suitable for those with other neurological diseases, severe language comprehension issues, significant memory problems, uncontrolled substance dependence, or serious mood or behavioral disorders needing specialized treatment.Check my eligibility

What is being tested?

The study tests a tailored Acceptance and Commitment Therapy (ACT) called 'ACT for Aphasia', designed to help improve communication skills, psychosocial adjustment, and life quality in stroke survivors with aphasia. The therapy will be refined through survivor feedback across two cohorts.See study design

What are the potential side effects?

As this is a psychological/behavioral intervention focusing on therapy rather than medication, traditional physical side effects are not expected. However, participants may experience emotional discomfort as they engage with the therapeutic process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have speech difficulties due to a stroke in the left side of my brain.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and post-treatment (within one week of completing the treatment phase)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and post-treatment (within one week of completing the treatment phase)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and post-treatment (within one week of completing the treatment phase) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean scores on the Client Satisfaction Questionnaire - 8

Secondary outcome measures

Brain

Change in mean scores on the Acceptance and Action Questionnaire II

Change in mean scores on the Aphasia Outcome Measure

+4 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Acceptance and Commitment Therapy adapted for aphasiaExperimental Treatment1 Intervention

There is only a single study arm, in which the adapted intervention will be developed using a successive cohort design.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Acceptance and Commitment Therapy for aphasia

2021

N/A

~20

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH

1,963 Previous Clinical Trials

2,674,721 Total Patients Enrolled

3 Trials studying Aphasia

64 Patients Enrolled for Aphasia

University of PittsburghLead Sponsor

1,719 Previous Clinical Trials

16,342,321 Total Patients Enrolled

3 Trials studying Aphasia

78 Patients Enrolled for Aphasia

University of DelawareOTHER

154 Previous Clinical Trials

25,191 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current openings for participants in this experiment?

"As per the information available on clinicaltrials.gov, recruitment for this medical trial is currently underway. The study was first listed on November 2nd 2021 and has since been modified in February 14th 2022."

Answered by AI

How many individuals is this medical trial recruiting?

"Affirmative. Online records held on clinicaltrials.gov show that this medical trial, initially launched on November 2nd 2021, is actively recruiting participants. The study needs to acquire 21 individuals from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Adapting Acceptance and Commitment Therapy for Stroke Survivors With Aphasia

William Evans 2021. "Adapting Acceptance and Commitment Therapy for Stroke Survivors With Aphasia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04984239.